lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter

lncRNA CISAL Inhibits BRCA1 Transcription by Forming a Tertiary Structure at Its Promoter

Summary: Cisplatin-based neoadjuvant chemotherapy has been shown to improve survival in patients with squamous cell carcinoma (SCC), but clinical biomarkers to predict chemosensitivity remain elusive. Here, we show the long noncoding RNA (lncRNA) LINC01011, which we termed cisplatin-sensitivity-asso...

Full description

Bibliographic Details
Main Authors: Song Fan, Tian Tian, Xiaobin Lv, Xinyuan Lei, Zhaohui Yang, Mo Liu, Faya Liang, Shunrong Li, Xiaofeng Lin, Zhaoyu Lin, Shule Xie, Bowen Li, Weixiong Chen, Guokai Pan, Xinyu Lin, Zhanpeng Ou, Yin Zhang, Yu Peng, Liping Xiao, Lizao Zhang, Sheng Sun, Hanqing Zhang, Sigeng Lin, Qunxing Li, Binghui Zeng, Filippos Kontos, Yi Ruan, Soldano Ferrone, Dechen Lin, Bakhos A. Tannous, Jinsong Li
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:iScience
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004220300183

Internet

http://www.sciencedirect.com/science/article/pii/S2589004220300183

Similar Items